Midi Health vs Gennev vs Inner Balance

Women seeking hormone therapy today have more telehealth options than ever before. But not all platforms approach hormone imbalance the same way, and understanding the differences between providers like Midi Health, Gennev, and Inner Balance can help you find a solution that addresses the root cause of your symptoms rather than simply managing them.

1. Inner Balance: Bioidentical Vaginal Hormone Therapy

Best for: Women seeking comprehensive hormone restoration through a single, science-backed formulation with predictable pricing

Inner Balance specializes exclusively in bioidentical hormone therapy delivered through optimized methods. Founded by Dr. Sarah Daccarett, MD, a board-certified physician specializing in women’s hormonal health and longevity medicine, the company operates in all 50 states through a telehealth model that eliminates traditional clinic visits.

How It Works

The flagship product, Oestra, is a compounded prescription vaginal cream combining bioidentical estradiol and progesterone in a single daily application. This delivery method leverages the vaginal mucosa’s rich blood supply to deliver hormones directly into systemic circulation.

Unlike oral medications that must pass through the digestive system and liver, vaginal delivery bypasses first-pass metabolism. This matters because:

• Oral hormones lose significant potency through liver processing
• Vaginal administration provides approximately 70% active unconjugated estrogen versus 35% with oral dosing
• More consistent hormone levels result in fewer side effects like daytime drowsiness

Pharmacokinetic research comparing vaginal and oral progesterone shows that the two routes produce different absorption and metabolite profiles. Vaginal administration avoids first-pass metabolism, which can reduce formation of some of the metabolites associated with sedation from oral micronized progesterone.

Key Benefits

Inner Balance users report significant improvements across multiple symptom categories:

• Vaginal dryness: 97% report improvement
• Sleep quality: 80.2% experience better sleep
• Mental health: 78.7% report mood improvements
• Heavy and painful periods: 90% report improvement
• Sex drive and arousal: Approximately 75% see positive changes
• Brain fog: Around 68% experience greater mental clarity

Some women report early changes in sleep and mood within the first few weeks, while other symptoms may take longer to improve. Response times vary by person.

Scientific Backing

The ELITE trial (Early versus Late Intervention Trial with Estradiol) studied oral estradiol with cyclical vaginal progesterone over five years. A later ELITE analysis found that the specific regimen of oral estradiol plus 45 mg of vaginal progesterone for 10 days per month did not provide adequate long-term endometrial protection. Separately, the main ELITE trial found slower progression of carotid artery wall thickness when estradiol was started within six years of menopause, but it did not establish a reduction in cardiovascular events.

What Makes It Different

Single-formula convenience: Where other providers prescribe estrogen and progesterone separately, Oestra combines both bioidentical hormones in one daily application. Key advantages:

• Eliminates complexity of coordinating multiple prescriptions
• Single medication and refill schedule
• Simplified daily routine

Symptom-based treatment: Inner Balance uses a symptom-guided approach, adjusting treatment based on clinical evaluation, symptoms, and response rather than relying on hormone lab values alone. Labs are optional when clinically appropriate.

Progesterone priority: Progesterone dose, formulation, and delivery route can affect both treatment response and tolerability. Inner Balance includes bioidentical progesterone alongside estradiol as part of its hormone-restoration approach, with dosing individualized according to symptoms and clinical guidance.

Transparent pricing: Unlike insurance-based providers where final costs depend on coverage, deductibles, and formulary, Inner Balance offers predictable monthly pricing with no billing surprises.

Additional Products

Beyond Oestra, Inner Balance offers complementary solutions:

BodyMatched Anti-Aging Face Cream: A prescription-strength topical formulated with bioidentical estriol and anti-aging compounds. Clinical data shows 61-100% improvement in skin elasticity and firmness, addressing the root cause of hormonally aging skin.

Libida: A prescription sublingual tablet for on-demand libido support, combining bremelanotide and oxytocin. Taken 45-60 minutes before intimacy, effects can last 24-72 hours. Starting from $199/month.

NAD+: A prescription, needle-free sublingual NAD+ therapy designed for women who want daily, long-term cellular support. This supports cellular energy production, natural repair processes, brain clarity, and stress resilience. Starting from $199/month.

Who It’s Best For

• Women 21+ experiencing perimenopause, menopause, endometriosis, PCOS, or postpartum hormonal changes
• Those who prefer predictable, transparent pricing without insurance complexity
• Women wanting a single comprehensive solution rather than multiple separate prescriptions
• Patients who have tried oral or topical hormones without adequate relief
• Women who prefer a vaginal delivery method that bypasses first-pass metabolism and can provide systemic hormone absorption

Cost and Access

• First 6 months: $199/month (90-day supply)
• After 6 months: $99.50/month (90-day supply)
• Oestra money-back guarantee: 180 days (full 6 months)
• HSA/FSA eligible: Yes
• Insurance: Cash-pay model with predictable pricing

The telehealth process involves completing a 5-minute health assessment, receiving physician approval within 24-48 hours, and having medications shipped directly to your home with free shipping. Unlimited access to healthcare experts is included for ongoing support and dose adjustments.

Estimated Year 1 Cost: $1,791 (includes prescription treatment, shipping, and clinical follow-up)

Estimated Year 2+ Cost: $1,194/year

2. Midi Health

Midi Health is a telehealth provider that raised $100 million in Series D funding and holds a valuation exceeding $1 billion. The company accepts most major PPO insurance plans and offers hormone therapy alongside other services including GLP-1 weight management programs.

How It Works

Midi Health provides hormone therapy through multiple delivery methods including pills, patches, gels, and creams. Patients work with menopause-certified clinicians during video consultations.

The key distinction: Midi prescribes estrogen and progesterone as separate medications rather than a combined formulation. This means:

• Patients coordinate multiple prescriptions
• Potentially different pharmacies
• Separate refill schedules

Key Features

• Insurance acceptance with most major PPO plans
• Comprehensive services including GLP-1 weight management and non-hormonal alternatives
• Multiple delivery methods available
• Access to menopause-certified clinicians

Cost Structure

With Insurance:

• Initial consultation: Cost depends on your plan’s copay, deductible, and coinsurance
• Follow-up visits: Cost varies by insurance plan
• Medications: Separate pharmacy costs based on prescription and coverage

Self-Pay:

• Initial consultation: $250
• Follow-up visits: $150 each
• Medications: Variable

Estimated First-Year Total:

• Total costs vary based on insurance coverage, visit frequency, prescribed medications, deductibles, copays, and other services.

Primary Focus

The insurance-based model creates variable, unpredictable costs. Separate prescriptions for estrogen and progesterone add coordination complexity. No money-back guarantee is offered, which is standard for insurance-billed medical services.

3. Gennev

Gennev was founded in 2016 and has operated for 10 years. The company was acquired by Unified Women’s Healthcare in October 2022 and continues to operate under the Gennev brand. The platform offers hormone therapy alongside registered dietitian consultations.

How It Works

Gennev provides hormone therapy through traditional delivery methods including pills, patches, and creams. Like Midi Health, prescriptions for estrogen and progesterone are written separately. The platform differentiates itself by offering registered dietitian access, with 50-minute initial nutrition consultations available.

Video consultations with physicians cover symptom assessment and treatment planning. Gennev has also developed over-the-counter menopause products, although its online store currently states that product sales are paused while the company focuses on virtual care.

Key Features

• Registered dietitian access: $199 initial consultation, $119 follow-ups
• Operating since 2016
• Menopause-focused virtual care with physician and registered dietitian support
• Insurance coverage available through multiple major carriers, with eligibility varying by specific plan

Cost Structure

Self-Pay:

• Initial physician visit: $250
• Follow-up visits: $199 each
• Medications: Separate pharmacy costs

Estimated First-Year Total (Self-Pay): $1,347-$1,447 (plus pharmacy and optional dietitian costs)

Service Approach

Higher follow-up costs ($199 vs $150 for Midi) can add up over time, particularly for women requiring ongoing care adjustments. The 2022 ownership transition to Unified Women’s Healthcare may have affected operations.

Why Inner Balance Delivers Comprehensive Hormone Restoration

Choosing hormone therapy depends on your specific symptoms, priorities, and circumstances. What matters most is addressing the root cause, hormone imbalance, rather than treating individual symptoms in isolation.

Inner Balance’s Oestra provides a comprehensive single-formula solution backed by clinical research. The vaginal delivery method offers genuine advantages in bioavailability and consistency, and the transparent pricing eliminates insurance billing complexity.

The Inner Balance Advantage

Simplified hormone therapy: One daily application provides both estradiol and progesterone, eliminating the complexity of multiple prescriptions and pharmacy coordination.

Science-backed delivery: Vaginal administration bypasses first-pass liver metabolism, delivering higher proportions of active hormones with more consistent blood levels and fewer side effects.

Predictable investment: Transparent pricing means you know exactly what you’ll pay each month, with no surprise insurance denials or formulary changes.

Proven results: With 97% of users reporting improvement in vaginal dryness, 80% experiencing better sleep, and nearly 79% seeing mood improvements, Oestra addresses multiple symptoms simultaneously.

Expert support included: Unlimited access to healthcare professionals ensures ongoing guidance and dose adjustments as your needs change.

What to Expect with Inner Balance

The telehealth process is straightforward:

• Complete a 5-minute health assessment
• Receive physician review within 24-48 hours
• Medications ship directly to your home
• Access ongoing support for questions and adjustments

The 180-day money-back guarantee on Oestra™ provides confidence to try the approach risk-free. Women transitioning from oral or patch therapy often notice differences within the first few weeks as they experience enhanced bioavailability.

Hormone restoration, not just symptom management, creates lasting improvements in energy, mood, sleep, and quality of life. Inner Balance specializes in delivering bioidentical hormones through methods designed for maximum effectiveness and convenience.

Frequently Asked Questions

How do I know which hormone therapy provider is right for me?

Start by identifying your primary concerns and priorities. If you’re experiencing classic hormonal symptoms like brain fog, sleep disruption, mood changes, and low libido, and want focused hormone restoration with predictable pricing, Inner Balance’s targeted approach may serve you best. Consider whether you prefer a single combined formulation or are willing to manage multiple separate prescriptions. Your decision should align with your treatment goals and practical preferences.

Why isn’t traditional HRT working for my symptoms?

Several factors can explain why conventional hormone therapy falls short. Oral estrogen undergoes first-pass liver metabolism, converting much of the active hormone into metabolites before it reaches target tissues. Many providers also prescribe synthetic progestins rather than bioidentical progesterone, a critical distinction since progestins behave differently at the cellular level. Delivery method, dose, and hormone type all significantly impact treatment response.

Can I switch from my current hormone therapy to Inner Balance?

Yes, many women transition to Inner Balance after trying other approaches. The onboarding process includes a health assessment that accounts for your current treatment. Your Inner Balance care team can guide the transition, adjusting doses based on your symptoms. Most women notice differences within the first few weeks as they experience the higher bioavailability of vaginal delivery compared to oral or topical methods.

What’s the difference between bioidentical and synthetic hormones?

Bioidentical hormones are molecularly identical to the estradiol, progesterone, and testosterone your body naturally produces. Bioidentical estradiol and progesterone are chemically identical to hormones produced by the human body. Synthetic progestins have different molecular structures and pharmacologic effects, so their benefits, risks, and side-effect profiles can differ from micronized progesterone; however, tolerability also depends on the specific hormone, dose, delivery route, and individual patient, as reflected in menopause guidance.

Why does the delivery method matter for hormone therapy?

Delivery method significantly impacts how much active hormone reaches your tissues. Oral hormones must pass through the digestive system and liver, where a substantial portion is converted to inactive metabolites. Vaginal progesterone bypasses first-pass liver metabolism and has pharmacokinetic properties that differ from oral progesterone. The ELITE trial used cyclical vaginal progesterone alongside oral estradiol, although a later analysis found that the specific progesterone regimen studied did not provide adequate long-term endometrial protection.